Key result
Simvastatin withdrawal in rat vascular smooth muscle cells caused a rebound increase in AT1-R mRNA, AT1-R protein, and AngII-mediated phosphorylation of ERK1/2.
Why the study?
Does statin withdrawal increase Angiotensin II signaling and AT1 receptor expression in vascular smooth muscle cells?
Does statin withdrawal increase Angiotensin II signaling and AT1 receptor expression in vascular smooth muscle cells?
Acute statin withdrawal induces a rebound increase in Angiotensin II signaling via upregulation of AT1 receptors, providing a potential mechanism for the vascular dysfunction associated with statin discontinuation.
Answers are grounded in this paper and cite their sources.
Statin withdrawal may heighten vascular risk via AT1 rebound; leaves open clinical relevance and need for human studies.
Acute discontinuation of statins induces vascular dysfunction and increases cardiovascular events. The mechanisms underlying these events are under investigation. We showed an increase in angiotensin II (AngII) signaling after acute statin withdrawal. We investigated whether AngII-AT1-receptor expression (AT1-R mRNA) and receptor protein (AT1-R) levels mediate increased AngII signaling. In rat aortic vascular smooth muscle cells (VSMC), simvastatin (0.3 to 3 microM for 24 hours) resulted in concentration-dependent inhibition of AngII-stimulated phosphorylation of extracellular-signal regulated kinase 1/2 ERK1/2 (-67 +/- 5% with 3 microM; P < 0.001) and decreased AT1-R mRNA (-34 +/- 8% with 3 microM; P < 0.01) and AT1-R protein (-32 +/- 6% with 3 microM; P < 0.01). Removal of simvastatin led to a rebound increase in mRNA-AT1-R (+39 +/- 2%, P < 0.01), AT1-R protein (+46 +/- 2%; P < 0.01), and AngII-mediated phosphorylation of ERK1/2 (+36 +/- 3%; P < 0.01). The increase in receptor expression was present at 1 hour and lasted for 4 hours, whereas increased AT1-R protein and AngII signaling started at 2 hours and lasted for nearly 2 hours. In summary, increased AngII signaling after statin withdrawal is most likely due to increases in AT1-R number due to increased transcription. The increase in AngII activity may contribute to the vascular dysfunction associated with statin withdrawal.
No takes yet. Share an insight, caveat, or question.
Castejón et al. (2007) studied this question. Simvastatin withdrawal vs. Simvastatin treatment was evaluated on AT1-R mRNA, AT1-R protein, and AngII-mediated phosphorylation of ERK1/2 (p=<0.01). Simvastatin withdrawal in rat vascular smooth muscle cells caused a rebound increase in AT1-R mRNA, AT1-R protein, and AngII-mediated phosphorylation of ERK1/2.
Synapse has enriched 10 related papers. Consider them for comparative context: